The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort
Open accessAbstract
BACKGROUND: Genetic modifiers are important clues for the identification of therapeutic targets in neurodegenerative diseases. Huntington disease (HD) is one of the most common autosomal dominant inherited neurodegenerative diseases. The clinical symptoms include motor abnormalities, cognitive decline and behavioral disturbances. Symptom onset is typically between 40 and 50 years of age, but can vary by several decades in extreme cases and this is in part determined by modifying genetic factors. The metabolic master regulator PGC-1α, coded by the PPARGC1A gene, coordinates cellular respiration and was shown to play a role in neurodegenerative diseases, including HD. METHODS: Using a candidate gene approach we analyzed a large European cohort (n = 1706) from the REGISTRY study for associations between PPARGC1A genotype and age at onset (AO) in HD. RESULTS: We report that a coding variant (rs3736265) in PPARGC1A is associated with an earlier motor AO in men but not women carrying the HD mutation. CONCLUSIONS: These results further strengthen the evidence for a role of PGC-1α in HD and unexpectedly suggest a gender effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In populations with neurological damage, such as multiple sclerosis, MBIs have demonstrated benefits in QoL [14], as well as improvements for people experiencing depression [15].”
From Mindfulness for pain, depression, anxiety, and quality of life in people with spinal cord injury: A systematic review (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredIn the citing paper
“Thomas et al127 reported significant positive changes in physical health assessed by the Multiple Sclerosis Impact Scale (MSIS-29) and vitality as measured by the SF-36 in the intervention group 12 months after the treatment.”
From Quality of life in adults with multiple sclerosis: A systematic review (2020) · cites this paper as [127]
In the citing paper
“Three studies were specifically directed towards the treatment of fatigue112 126 127 by light guided imagery or self-management programmes. Both the imagery and self-management group intervention approaches were successful, whereas the individual self-management programme did not show significant improvement.”
From Quality of life in adults with multiple sclerosis: A systematic review (2020) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
NPS@: Network Protein Sequence Analysis
Combet, C., Blanchet, C., Geourjon, C., & Deléage, G. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01540-6 · Cited by 1,761
Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006) · Cell · doi:10.1016/j.cell.2006.09.015 · Cited by 1,012
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L., Eklund, A. C., Zhang‐James, Y., Kim, P. D., Hauser, M. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001059 · Cited by 868
A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy
Ruas, J. L., White, J. P., Rao, R. R., Kleiner, S., Brannan, K. T., Harrison, B. C., Greene, N. P., Wu, J., Estall, J. L., Irving, B. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.10.050 · Cited by 677
Weydt, P., Pineda, V. V., Torrence, A. E., Libby, R. T., Satterfield, T. F., Lazarowski, E. R., Gilbert, M. L., Morton, G. J., Bammler, T. K., Strand, A. D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.004 · Cited by 562
Self-citationCAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
Lee, J.-H., Ramos, E. M., Lee, J.-H., Gillis, T., Mysore, J. S., Hayden, M. R., Warby, S. C., Morrison, P., NANCE, M. A., Ross, C. A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318249f683 · Cited by 383
Self-citationSex differences in molecular neuroscience: from fruit flies to humans
JAZIN, E. E., & Cahill, L. F. (2009) · Nature reviews. Neuroscience · doi:10.1038/nrn2754 · Cited by 246
Cited by
Sorted by citations
Items 201–206 of 206
Efek Aktivitas Fisik dan Latihan pada Penderita Penyakit Huntington: Systematic Review
Bachtiar, F., & Condrowati, C. (2022) · Malahayati Nursing Journal · doi:10.33024/mnj.v5i2.5895
Simmonds, K. P., Chavez, A. A., Venkatachalam, A. M., & Ifejika, N. L. (2024) · medRxiv · doi:10.1101/2024.11.12.24317216
Bayram, E. (2025) · Springer eBooks · doi:10.1007/978-3-031-87228-0_6
Chen, R., Ma, M. L., Lv, P., Lin, J., Li, M. C., Yan, Y., Jin, X., Dai, X., 纪宗斐, Chen, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14111635
Sex-related differences in Huntington‘s disease: a scoping review
Hemicker, G., Schwarzová, K., Cerejo, C., Labrecque, S., Peball, M., Carbone, F., Wimmer, B., Djamshidian, A., Seppi, K., & Heim, B. (2026) · Biology of Sex Differences · doi:10.1186/s13293-026-00895-9
Does Hemispheric Asymmetry Reduction in Older Adults (HAROLD) in motor cortex reflect compensation?Preprint
Henson, R. N., & Knights, E. (2023) · OSF Preprints (OSF Preprints)
Metadata
- Authors
- For the European Huntington Disease Network, Weydt, P., Soyal, S. M., Landwehrmeyer, G. B., & Patsch, W.
- Affiliations
- Universität Ulm (DE)
- Paracelsus Medical University (AT)
- Corresponding author
- Weydt, Patrick
- Venue
- BMC Neurology
- Published
- 2014-01-02
- Volume
- 14
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1471-2377 (ISSN-L)
- PMC
- PMC3880172
- OpenAlex
- W1990817194
- Cited by
- 206
- References
- 36
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 8 · 2023: 8 · 2022: 4 · 2021: 50 · 2020: 25 · 2019: 13 · 2018: 24 · 2017: 29 · 2016: 21 · 2015: 5 · 2014: 8
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Neurology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Huntington's Disease Network
- Austrian Science Fund (P 19893)
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Paracelsus Medizinische Privatuniversität
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- Huntington's disease, PGC-1α, single nucleotide polymorphisms, age of onset, genetic modifiers, sex differences, motor symptoms, neurodegeneration, candidate gene association
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Europe, Female, Humans, Huntington Disease, Male, Registries, Transcription Factors, Cohort Studies, Open Reading Frames, Age of Onset, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
